Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1238
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side ; volume:34 ; number:1 ; day:1 ; month:8 ; year:2007 ; pages:211-212 ; date:1.2008
Intensive care medicine ; 34, Heft 1 (1.8.2007), 211-212, 1.2008
- Urheber
-
Veen, E. J. W. van
Monteban-Kooistra, W. E.
Meertens, J. H. J. M.
Ligtenberg, J. J. M.
Tulleken, J. E.
Zijlstra, J. G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00134-007-0810-0
- URN
-
urn:nbn:de:101:1-2021080706144923840508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Veen, E. J. W. van
- Monteban-Kooistra, W. E.
- Meertens, J. H. J. M.
- Ligtenberg, J. J. M.
- Tulleken, J. E.
- Zijlstra, J. G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Errata “Recombinant Activated Factor VII: Mechanisms of Action and Current Indications”
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery
Recombinant activated factor VII in cardiac surgery – first, do no harm
Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells
Errata “Recombinant Activated Factor VII: Mechanisms of Action and Current Indications”
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery
Recombinant activated factor VII in cardiac surgery – first, do no harm
Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor
Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells
Errata “Recombinant Activated Factor VII: Mechanisms of Action and Current Indications”
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery
Recombinant activated factor VII in cardiac surgery – first, do no harm
Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
Alleviating Recombinant Tissue Plasminogen Activator‐induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor